Any patient can access Signos’ system, which uses an AI platform and an off-the-shelf continuous glucose monitor, or CGM, from Dexcom.
#stockmarket #breaking
FDA approves first-ever glucose monitoring system for weight loss from Signos – CNBC
Related Posts
The top fell off Australia’s first orbital-class rocket, delaying its launch – Ars Technica $GOOG $NVDA $MSFT
The Australian startup behind the Eris rocket says the rest of the vehicle was undamaged. #stockmarket #breaking
Inflation quashed household income gains in 2024, census finds – The Washington Post
The U.S. Census Bureau found that the richest Americans’ income rose last year, and women and Black people lost ground.…
FDA approves weight-loss drug Zepbound to treat sleep apnea – The Washington Post
It marks the first medication for certain patients with the condition. #stockmarket #breaking